TABLE 2.
MICs for E. coli transconjugants and transformants with carbapenemases
| Carbapenemase class or strain | MIC (μg/ml) of drug |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ceftazidime | Ceftazidime-NXL104 | Ceftazidime-clavulanate | Aztreonam | Aztreonam-NXL104 | Cefotaxime | Piperacillin | Piperacillin-tazobactam | Imipenem | Meropenem | Ertapenem | |
| Class A | |||||||||||
| J62 KPC-3 | 64 | 0.25 | 32 | >128 | 0.06 | 128 | >128 | >128 | 8 | 8 | 8 |
| JM109 NMCA | 0.25 | ≤0.06 | 0.125 | 16 | ≤0.03 | ≤0.125 | 32 | 2 | 2 | 1 | 2 |
| Class B | |||||||||||
| DH5α IMP-1 | 16 | 4 | 16 | ≤0.03 | ≤0.03 | 4 | 2 | 1 | 0.5 | 0.125 | 0.125 |
| DH5α NDMa | >256 | >256 | >32 | 8 | 0.125 | 128 | 128 | 128 | 8 | 4 | 8 |
| DH5α NDM (cloned pUC19) | >256 | >256 | >32 | 0.06 | ≤0.03 | 256 | >128 | >128 | 32 | 16 | 16 |
| Class D | |||||||||||
| DH5α OXA-48 | ≤0.125 | ≤0.060 | 0.125 | ≤0.030 | ≤0.030 | 0.25 | 128 | 32 | 2 | 0.125 | 0.5 |
| Recipients | |||||||||||
| DH5α | ≤0.125 | ≤0.06 | ≤0.06 | ≤0.03 | ≤0.03 | ≤0.125 | 1 | 1 | 0.125 | ≤0.03 | ≤0.03 |
| J62 | ≤0.125 | ≤0.06 | 0.125 | ≤0.03 | ≤0.03 | ≤0.125 | 2 | 2 | 0.125 | ≤0.03 | ≤0.03 |
| JM83 | ≤0.125 | 0.125 | 0.125 | 0.06 | 0.06 | ≤0.125 | 2 | 2 | 0.25 | ≤0.03 | ≤0.03 |
Also produced CIT-type AmpC β−lactamase.